What can we expect of collaborative review groups of cochrane collaboration in neuropaediatrics?;¿Qué podemos esperar de los Grupos Colaboradores de Revisión de la Colaboración Cochrane en neuropediatría?

Revista de Neurologia

Volumn 43, Issue 10, 2006, Pages 589-597

  González De Dios, Javier ^a,c   Balaguer Santamaria J A ^b  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c NONE   (Spain)

Author keywords

Clinical trials; Cochrane collaboration; Evidence based decision making; Evidence based medicine; Paediatric neurology; Systematic reviews

Indexed keywords

ARTICLE; AUTISM; BACTERIAL MENINGITIS; BELL PALSY; BIBLIOMETRICS; BRAIN HEMORRHAGE; CEREBRAL PALSY; COCHRANE LIBRARY; DEVELOPMENTAL DISORDER; EPILEPSY; GUILLAIN BARRE SYNDROME; HEADACHE; INFECTION; LEARNING DISORDER; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; PAIN; PALLIATIVE THERAPY; PERINATAL ASPHYXIA; PSYCHOSOCIAL DISORDER; RESEARCH; RESPIRATORY TRACT INFECTION; EVIDENCE BASED MEDICINE; LITERATURE; NEUROLOGY; PEDIATRICS; REVIEW;

BIBLIOMETRICS; EVIDENCE-BASED MEDICINE; NEUROLOGY; PEDIATRICS; REVIEW LITERATURE;

EID: 35348821369     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4310.2006213     Document Type: Article

References (141)

1. Muir Gray JA. Evidence-based healthcare. How to make health policy and management decisions. 2 ed. Edinburgh: Churchill-Livingstone; 2003.
2. López-Arrieta JM, Qizilbash N. La medicina basada en pruebas: revisiones sistemáticas. La Colaboración Cochrane. Med Clin (Barc) 1996; 107: 581-5.
3. González de Dios J. Búsqueda de información en pediatría basada en la evidencia (II): fuentes de información secundarias y primarias. Rev Esp Pediatr 2003; 59: 259-73.
4. Balaguer-Santamaría A, González de Dios J, Bonfill X. La Colaboración Cochrane por fuera y por dentro. Rev Esp Pediatr 2005; 61: 296-303.
5. González de Dios J. Las mejores evidencias (o pruebas) científicas (II): la revisión sistemática. Rev Esp Pediatr 1999; 55: 250-6.
6. Balaguer-Santamaría JA, González de Dios J. Digiriendo la información científica. Excelencias y limitaciones de las revisiones sistemáticas y metaanálisis. Acta Pediatr Esp 2004; 62: 4-10.
7. Gisbert JP, Bonfill X. ¿Cómo realizar, evaluar y utilizar revisiones sistemáticas y metaanálisis? Gastroenterol Hepatol 2004; 27: 129-49.
8. Akobeng AK. Understanding systematic reviews and meta-analysis. Arch Dis Child 2005; 90: 845-8.
9. Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, et al. Methodology and reports of systematic reviews and meta-analyses. A comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998; 280: 278-80.
10. González de Dios J. Las mejores evidencias (o pruebas) científicas (III): el metaanálisis. Rev Esp Pediatr 1999; 55: 368-76.
11. Allam MF, Del Castillo AS, Navajas RFC. Metaanálisis: la ciencia de la revisión en neurología. Rev Neurol 2005; 40: 222-8.
12. Jovell AJ, Navarro Rubio MD. Evaluación de la evidencia científica. Med Clin (Barc) 1995; 105: 740-3.
13. González de Dios J. Niveles de calidad de la evidencia científica. Pediatría Integral 1999; 4: 108-13.
14. Tudur-Smith C, Marson AG, Williamson PR. Carbamazepine versus phenobarbitone monotherapy for epilepsy. The Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD001904. DOI: 10.1002/14651858.CD001904.
15. Tudur-Smith C, Marson AG, Clough HE, Williamson PR. Carbamazepine versus phenytoin monotherapy for epilepsy. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001911. DOI: 10.1002/14651858.CD001911.
16. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW, on behalf of the Epilepsy Monotherapy Trialists. Carbamazepine versus valproate monotherapy for epilepsy. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD001030. DOI: 10.1002/14651858.CD001030.
17. Appleton R, Martland T, Phillips B. Drug management for acute tonicclonic convulsions including convulsive status epilepticus in children. The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD001905. DOI: 10.1002/14651858.CD001905.
18. Sirven JI, Sperling M, Wingerchuk DM. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. The Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD001902. DOI: 10.1002/14651858. CD001902.
19. Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003032. DOI: 10.1002/14651858.CD003032.
20. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD001909. DOI: 10.1002/14651858.CD001909.
21. Castillo S, Schmidt DB, White S. Oxcarbazepine add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002028. DOI: 10.1002/14651858.CD002028.
22. Taylor S, Tudur-Smith C, Williamson PR, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. The Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD002217. DOI: 10.1002/14651858.CD002217.
23. Tudur-Smith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. The Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD001769. DOI: 10.1002/14651858.CD001769.
24. Pereira J, Marson AG, Hutton JL. Tiagabine add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD001908. DOI: 10.1002/14651858.CD001908.
25. Jette NJ, Marson AG, Hutton JL. Topiramate add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD001417. DOI: 10.1002/14651858.CD001417.
26. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. Gabapentin add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD001415. DOI: 10.1002/14651858.CD001415.
27. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001416. DOI: 10.1002/14651858.CD001416.
28. Chaisewikul R, Baillie N, Marson AG. Calcium antagonists as an addon therapy for drug-resistant epilepsy. The Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD002750. DOI: 10.1002/14651858.CD002750.
29. Hancock E, Osborne J. Treatment of infantile spasms. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD001770. DOI: 10.1002/14651858.CD001770.
30. Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003277. DOI: 10.1002/14651858.CD003277.
31. Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures. The Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD002896. DOI: 10.1002/14651858.CD002896.
32. Ranganathan LN, Ramaratnam S. Vitamins for epilepsy. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004304. DOI: 10.1002/14651858.CD004304.
33. Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments for epilepsy. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD002029. DOI: 10.1002/14651858.CD002029.
34. Bradley P, Lindsay B. Specialist epilepsy nurses for treating epilepsy. The Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD001907. DOI: 10.1002/14651858.CD001907.
35. Leach JP, Marson AG, Hutton JL. Remacemide for drug-resistant localization related epilepsy. The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD001900. DOI: 10.1002/14651858.CD001900.
36. Levy R, Cooper P. Ketogenic diet for epilepsy. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD001903. DOI: 10. 1002/14651858.CD001903.
37. Ramaratnam S, Sridharan K. Yoga for epilepsy. The Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001524. DOI: 10.1002/14651858. CD001524.
38. Hughes RAC, Van der Meché FGA. Corticosteroids for Guillain-Barré syndrome. The Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001446. DOI: 10.1002/14651858.CD001446.
39. Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002828. DOI: 10.1002/14651858.CD002828.
40. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003725. DOI: 10.1002/14651858.CD003725.
41. Hughes RAC, Raphaël JC, Swan AV, Van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD002063. DOI: 10.1002/14651858. CD002063.
42. Gajdos P, Chevret S, Toyka K. Intravenous immunoglobulin for myasthenia gravis. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD002277. DOI: 10.1002/14651858.CD002277.
43. Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001798. DOI: 10.1002/14651858.CD001798
44. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD002275. DOI: 10.1002/14651858.CD002275.
45. Mummery CJ, Copeland SA, Rose MR. Scapular fixation in muscular dystrophy. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003278. DOI: 10.1002/14651858.CD003278.
46. Cornblath DD, Hollingshead JRF. Tramadol for neuropathic pain. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003726. DOI: 10.1002/14651858.CD003726.
47. Maddison P, Newsom-Davis J. Treatment for Lambert-Eaton myasthenic syndrome. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003279. DOI: 10.1002/14651858.CD003279.
48. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD004303. DOI: 10.1002/14651858.CD004303.
49. Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD001869. DOI: 10.1002/14651858.CD001869.
50. He L, Zhou D, Wu B, Li N, Zhou MK. Acupuncture for Bell's palsy. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD002914. DOI: 10.1002/14651858.CD002914.
51. Salinas RA, Álvarez G, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD001942. DOI: 10.1002/14651858.CD001942.
52. Quinlivan R, Beynon RJ. Pharmacological and nutritional treatment for McArdle's disease (glycogen storage disease type V). The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003458. DOI: 10.1002/14651858. CD003458.
53. Annane D, Miller R, Barnes P. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003218. DOI: 10.1002/14651858.CD003218.
54. Sinha Y, Silove N, Wheeler D, Williams K. Auditory integration training and other sound therapies for autism spectrum disorders. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003681. DOI: 10.1002/14651858.CD003681.
55. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003497. DOI: 10.1002/14651858.CD003497.
56. Bjornstad G, Montgomery P. Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005042. DOI: 10.1002/14651858.CD005042.
57. Sleigh G, Sullivan PB, Thomas AG. Gastrostomy feeding versus oral feeding alone for children with cerebral palsy. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003943. DOI: 10.1002/14651858.CD003943.
58. Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and caseinfree diets for autistic spectrum disorder. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003498. DOI: 10.1002/14651858.CD003498.
59. Barlow J, Parsons J. Group-based parent-training programmes for improving emotional and behavioural adjustment in 0-3 year old children. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD003680. DOI: 10.1002/14651858.CD003680.
60. Coren E, Barlow J. Individual and group-based parenting programmes for improving psychosocial outcomes for teenage parents and their children. The Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD002964. DOI: 10.1002/14651858.CD002964.
61. Martins S, Logan S, Gilbert R. Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. The Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD001444. DOI: 10.1002/14651858.CD001444.
62. Diggle T, McConachie HR, Randle VRL. Parent-mediated early intervention for young children with autism spectrum disorder. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003496. DOI: 10.1002/14651858. CD003496.
63. Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD004110. DOI: 10.1002/14651858.CD004110.
64. Wasiak J, Hoare B, Wallen M. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. The Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003469. DOI: 10.1002/14651858.CD003469.
65. Ade-Hall RA, Moore AP. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. The Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001408. DOI: 10.1002/14651858.CD001408.
66. Pennington L, Goldbart J, Marshall J. Speech and language therapy to improve the communication skills of children with cerebral palsy. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003466. DOI: 10.1002/14651858.CD003466.
67. Booth D, Evans DJ. Anticonvulsants for neonates with seizures. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004218. DOI: 10.1002/14651858.CD004218.
68. Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. The Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD001240. DOI: 10.1002/14651858.CD001240.
69. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003311. DOI: 10.1002/14651858.CD003311.
70. Okoromah CAN, Lesi FEA. Diazepam for treating tetanus. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003954. DOI: 10.1002/14651858.CD003954.
71. Whitelaw A, Kennedy CR, Brion LP. Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation. The Cochrane Data base of Systematic Reviews 2001, Issue 2. Art. No.: CD002270. DOI: 10.1002/14651858. CD002270.
72. Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003484. DOI: 10.1002/14651858. CD003484.
73. Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. The Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD002052. DOI: 10.1002/14651858. CD002052.
74. Whitelaw A. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD000498. DOI: 10.1002/14651858.CD000498.
75. McGuire W, Fowlie PW. Naloxone for narcotic-exposed newborn infants. The Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003483. DOI: 10.1002/14651858.CD003483.
76. McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003955. DOI: 10.1002/14651858.CD003955.
77. Osborn DA, Cole MJ, Jeffery HE. Opiate treatment for opiate withdrawal in newborn infants. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002059. DOI: 10.1002/14651858.CD002059.
78. Whitelaw A. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD001691. DOI: 10.1002/14651858. CD001691.
79. Whitelaw A. Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD000216. DOI: 10.1002/14651858.CD000216.
80. Osborn DA, Jeffery HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002053. DOI: 10.1002/14651858.CD002053.
81. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. The Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD001070. DOI: 10.1002/14651858. CD001070.
82. Shah S, Ohlsson A, Shah V. Intraventricular antibiotics for bacterial meningitis in neonates. The Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004496. DOI: 10.1002/14651858.CD004496.
83. Víctor S, Ryan SW. Drugs for preventing migraine headaches in children. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD002761. DOI: 10.1002/14651858.CD002761.
84. Pittler MH, Ernst E. Feverfew for preventing migraine. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD002286. DOI: 10.1002/14651858.CD002286.
85. Melchart D, Linde K, Berman B, White A, Vickers A, Allais G, et al. Acupuncture for idiopathic headache. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD001218. DOI: 10.1002/14651858.CD001218.
86. Bronfort G, Nilsson N, Haas M, Evans R, Goldsmith CH, Assendelft WJJ, et al. Non-invasive physical treatments for chronic/recurrent headache. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001878. DOI: 10.1002/14651858.CD001878.
87. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. The Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD000173. DOI: 10.1002/14651858.CD000173.
88. Ratilal B, Costa J, Sampaio C. Anticonvulsants for preventing seizures in patients with chronic subdural haematoma. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004893. DOI: 10.1002/14651858.CD004893.
89. Taricco M, Adone R, Pagliacci C, Telaro E. Pharmacological interventions for spasticity following spinal cord injury. The Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001131. DOI: 10.1002/14651858.CD001131.
90. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002244. DOI: 10.1002/14651858.CD002244.
91. Prasad K, Garner P. Steroids for treating cerebral malaria. The Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD000972. DOI: 10.1002/14651858.CD000972.
92. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain). The Cochrane Database of Systematic Reviews 1999, Issue 4. Art. No.: CD000215. DOI: 10.1002/14651858.CD000215.
93. Prasad K, Singhal T, Jain N, Gupta PK. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD001832. DOI: 10.1002/14651858.CD001832.
94. Van de Beek D, De Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD004405. DOI: 10.1002/14651858.CD004405.
95. González de Dios J. Toma de decisiones en neurología neonatal a través de las revisiones sistemáticas de la Colaboración Cochrane. Rev Neurol 2005; 40: 453-9.
96. Chaisewikul R, Privitera MD, Hutton JL, Marson AG. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD001901. DOI: 10.1002/14651858.CD001901.
97. Armijo JA, Sánchez B, González AB. Tratamiento de la epilepsia basado en la evidencia. Rev Neurol 2002; 35 (Supl 1): S59-73.
98. Arroyo S, Campistol J, Comes E, Fossas P, Martínez I, Padró L, et al. El tratamiento de las epilepsias. Guía terapéutica de la Sociedad Catalana de Neurología. Rev Neurol 1999; 29: 754-66.
99. Serrano-Castro PJ, Ramos-Lizana J, Pita-Calandre E, Camino-León R, Galán-Barranco JM, Rufo-Campos M, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: I. Criterios de inicio y cese y bases farmacológicas del tratamiento antiepiléptico. Rev Neurol 2005; 40: 563-71.
100. Sánchez-Álvarez JC, Galán-Barranco JM, Camino-Léon R, Pita-Calandre E, Ramos-Lizana J, Moreno-Alegre V, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: II. Terapéutica antiepiléptica crónica en el adulto y en el niño. Rev Neurol 2005; 40: 619-26.
101. Serrano-Castro PJ, Casado-Chocán JL, Mercadé-Cerdá JM, Altuzarra-Corral A, Rufo-Campos M, Moreno-Alegre V, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: III. Tratamiento antiepiléptico en situaciones especiales. Rev Neurol 2005; 40: 683-95.
102. Sánchez-Álvarez JC, Altuzarra-Corral A, Mercadé-Cerdá JM, Casado-Chocán JL, Moreno-Alegre V, Rufo-Campos M, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: IV. Principios generales de politerapia antiepiléptica y estrategias terapéuticas en epilepsia refractaria. Rev Neurol 2005; 40: 743-50.
103. Herranz JL. Gabapentina en niños y adolescentes con epilepsia. Rev Neurol 2002; 34: 384-7.
104. Herranz JL. Gabapentina: mecanismos de acción en el año 2003. Rev Neurol 2003: 36: 1159-65.
105. Casas-Fernández C. Datos actuales de la lamotrigina. Rev Neurol 2000; 30 (Supl 1): S120-5.
106. Rufo-Campos M. Características e indicaciones de la lamotrigina. Rev Neurol 2002; 35 (Supl 1): S74-84.
107. Herranz JL, Argumosa A. Características e indicaciones del levetiracetam. Rev Neurol 2002; 30 (Supl 1): S110-6.
108. Herranz JL, Argumosa A. Características e indicaciones de la oxcarbamacepina. Rev Neurol 2002; 35 (Supl 1): S101-9.
109. Horga de la Parte JF, Horga A. Oxcarbacepina en el tratamiento de la epilepsia. Revisión y actualización. Rev Neurol 2006; 42: 95-113.
110. Herranz JL. Datos actuales de la tiagabina. Rev Neurol 2000; 30 (Supl 1): S137-41.
111. Casas-Fernández C, Domingo-Jiménez R. Caracterí sticas e indicaciones de la tiagabina. Rev Neurol 2002; 35 (Supl 1): S96-100.
112. Herranz JL. Datos actuales sobre el topiramato. Rev Neurol 2000; 30 (Supl 1): S132-6.
113. Nieto-Barrera M. Características e indicaciones del topiramato. Rev Neurol 2002; 35 (Supl 1); S88-95.
114. Herranz JL, Sol JM, Hernández G, y Grupo Español Colaborativo de Gabapentina. Gabapentina asociada en 559 pacientes con epilepsias parciales. Estudio observacional multicéntrico. Rev Neurol 2000; 30: 1141-5.
115. Martínez-González MJ, Ruiz C, Garaizar C, Prats JM. Eficacia de la lamotrigina en la epilepsia infantil rebelde. Rev Neurol 2001; 33: 123-7.
116. Herranz JL, Rufo-Campos M, Arteaga R. Eficacia y tolerabilidad del levetiracetam en 43 niños y adolescentes con epilepsia. Rev Neurol 2003; 37: 1005-8.
117. Herranz JL, Argumosa A, Salas-Puig J, y Grupo Español de Estudio TRINOVA. Oxcarbamacepina en monoterapia en 324 pacientes con crisis parciales (estudio TRINOVA). Rev Neurol 2004; 39: 601-6.
118. Herranz JL. Topiramato: antiepiléptico de amplio espectro administrado a 224 pacientes con epilepsia rebelde. Rev Neurol 2000; 31: 822-8.
119. Martínez-González MJ, Garaizar C, Prats JM. Evolución de la epilepsia infantil rebelde tratada con topiramato. Rev Neurol 2001; 32: 405-8.
120. Reséndiz-Aparicio JC, Rodríguez-Rodríguez E, Contreras-Bernal J, Ceja-Moreno H, Barragán-Pérez E, Garza-Morales S, et al. Estudio abierto aleatorio y comparativo de la monoterapia con topiramato frente a carbamacepina en el tratamiento de pacientes pediátricos con epilepsia de reciente tratamiento. Rev Neurol 2004; 39: 201-4.
121. González de Dios J. Análisis bibliométrico de las revisiones sistemáticas en la Colaboración Cochrane Neonatal. Importancia en la toma de decisiones basada en pruebas en neonatología. An Pediatr (Barc) 2004; 60: 417-27.
122. González de Dios J. Áreas temáticas de estudio y grupos de investigación en la Colaboración Cochrane Neonatal. Rev Esp Pediatr 2004; 60: 194-210.
123. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003225.pub2. DOI: 10.1002/14651858.CD003225.pub2.
124. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003226.pub2. DOI: 10.1002/14651858.CD003226.pub2.
125. McCrory DC, Gray RN. Oral sumatriptan for acute migraine. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD002915. DOI: 10.1002/14651858.CD002915.
126. Oldman AD, Smith LA, McQuay HJ, Moore RA. Rizatriptan for acute migraine. The Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD003221. DOI: 10.1002/14651858.CD003221.
127. Smith LA, Oldman AD, McQuay HJ, Moore RA. Eletriptan for acute migraine. The Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD003224. DOI: 10.1002/14651858.CD003224.
128. Hernández JM, Artigas-Pallarés J, Martos-Pérez J, Palacios-Antón S, Fuentes-Biggi J, Belinchón-Carmona M, et al. Guía de buena práctica para la detección temprana de los trastornos del espectro autista. Rev Neurol 2005; 41: 237-45.
129. Díez-Cuervo A, Muñoz-Yunta JA, Fuentes-Biggi J, Canal-Bedia R, Idiazábal-Aletxa MA, Ferrari-Arroyo MJ, et al. Guía de buena práctica para el diagnóstico de los trastornos del espectro autista. Rev Neurol 2005; 41: 299-310.
130. Belinchón-Carmona M, Posada de la Paz M, Artigas-Pallarés J, Canal-Bedia R, Díez-Cuervo A, Ferrari-Arroyo MJ, et al. Guía de buena práctica para la investigación de los trastornos del espectro autista. Rev Neurol 2005; 41: 371-7.
131. Mallet S, Clarke M. How many Cochrane reviews are needed to cover existing evidence on the effects of healthcare interventions? Evidence Based Medicine 2003; 8: 100-1.
132. Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. The Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD001031. DOI: 10.1002/14651858.CD001031.
133. Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. The Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004426. DOI: 10.1002/14651858.CD004426.
134. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003723. DOI: 10.1002/14651858.CD003723.
135. Oates-Whitehead RM, Maconochie I, Baumer H, Stewart MER. Fluid therapy for acute bacterial meningitis. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004786. DOI: 10.1002/14651858.CD004786.
136. Olsen O, Middleton P, Ezzo J, Gotzsche PC, Hadhazy V, Herxheimer A, et al. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001; 323: 829-32.
137. Shea B, Moher D, Graham I, Pham B, Tugwell P. A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Eval Health Prof 2002; 25: 116-29.
138. Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994; 120: 667-76.
139. Mosteller F, Colditz GA. Understanding research synthesis (meta-analysis). Annu Rev Public Health 1996; 17: 1-23.
140. Walter SD, Irwig L, Glasziou PP. Meta-analysis of diagnostic tests with imperfect reference standards. J Clin Epidemiol 1999; 52: 943-51.
141. Green S, McDonald S. Cochrane Collaboration: more than systematic reviews? Intern Med J 2005; 35: 3-4.